AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 that is also used as an inhaled booster. It was developed by CanSino...

Recombinant adenovirus type-5 (Ad5) are being used by Ad5-nCoV, ImmunityBio and UQ-CSL V451. The Gam-COVID-Vac (aka Sputnik-V) product is innovative because...

company has a portfolio of vaccines under research including Ad5-EBOV to prevent Ebola and Ad5-nCoV for COVID-19. The company has previously collaborated with...

V by the Gamaleya Institute (February 2, 2021) Ad5-nCoV by CanSino Biologics Inc. (February 9, 2021) CoronaVac by Sinovac Research and Development Co...

5AD (radio station), Adelaide, South Australia, Australia Ad5-nCoV, COVID-19 vaccine Ad5-EBOV, Ebola vaccine 5 (disambiguation) AD (disambiguation) This...

tozinameran and mRNA-1273, the DNA vaccine ZyCoV-D as well as the viral vectors AZD1222, Ad26.COV2.S, Ad5-nCoV, and Sputnik V. In addition, genetic vaccines are...

clinical trials for Chinese COVID-19 vaccine Ad5-Ncov: Ifax". Reuters. 2020-12-07. Retrieved 2020-12-07. Eltahir N (9 August 2020). "CanSino to start Phase...

Biologics to conduct clinical trials for its COVID-19 vaccine candidate Ad5-nCoV at Dalhousie University in Nova Scotia. The NRC cited its "strong collaborative...

Biological Sciences at the University of Montreal. Starting in June, the Ad5-nCoV vaccine, developed by the Chinese company CanSino Biologics (Tianjin, China)...

vaccine-maker CanSino Biologics. It contains a human adenovirus serotype 5 vector (Ad5) with the glycoprotein gene from ZEBOV. Their findings were consistent with...

trials for Chinese COVID-19 vaccine Ad5-Ncov: Ifax". Reuters. 7 December 2020. Retrieved 7 December 2020. Eltahir N (9 August 2020). "CanSino to start...

on Ad26) is administered on the first day, and the second dose (based on Ad5) is administered on the 21st day to boost immune response. Both doses are...

reported that the first group of Russian volunteers for a Chinese vaccine, Ad5-nCoV, received the vaccine, with no side effects reported. On 22 September,...

ImmunityBio Inc is currently conducting phase 1 vaccine trials with their hAd5 vaccine in the United States and South Africa. ImmunityBio and BioVac plan...

refrigeration for several months. Sputnik V uses Ad26 for its first dose, which is the same as Janssen's only dose, and Ad5 for the second dose, which is the...

reduced viral load and prevents lung pathology in KI-hACE2 and Ad5-hACE2 mouse models of SARS-CoV-2. A patent filed by Gilead Sciences with a priority date...

countries in Asia, Europe, and Latin America. Production capacity for Ad5-NCov should reach 500 million doses in 2021. China pledged US$2 billion to support...

AdEasy. However, homologous recombination between the inserted cellular Ad5 sequence and the vector sequence, although rare, can restore the replication...

plasmid vaccine plus a recombinant adenovirus type 5 vector vaccine (DNA/rAd5), could prevent HIV. The vaccines were developed for HIV subtypes A, B and...

2017). "Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia"...

immunity to adenoviruses from previous exposure. The seroprevalence against Ad5 in the US population is as high as 40%–45%. Most Adenovirus vectors are...

Christensen DP, Dahllöf M, Lundh M, Rasmussen DN, Nielsen MD, Billestrup N, et al. (2011). "Histone deacetylase (HDAC) inhibition as a novel treatment...

Borisevich, Sergei V.; Naroditsky, Boris S.; Gintsburg, Alexander L. (20 February 2021). "Safety and efficacy of an rAd26 and rAd5 vector-based heterologous...

GRT-R910 is a self-amplifying mRNA delivering spike and T cell epitopes. hAd5-S+N delivers spike and nucleocapsid antigens via human adenovirus serotype...

Clutterbuck E (February 2021). "Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)". SSRN 3779160. Mahase E (February...

PMID 11912208. Hashimoto Y, Katayama H, Kiyokawa E, Ota S, Kurata T, Gotoh N, Otsuka N, Shibata M, Matsuda M (July 1998). "Phosphorylation of CrkII adaptor...

PMID 29761479. De Crescenzo F, D'Alò GL, Ostinelli EG, Ciabattini M, Di Franco V, Watanabe N, et al. (July 2022). "Comparative effects of pharmacological interventions...

of thyroid cancer and for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3...

September 2020 (Report). World Health Organization. hdl:10665/334125. WHO/2019-nCoV/Corticosteroids/2020.1. Archived from the original on 11 October 2020. Retrieved...

Elizabeth A., Hobson, Deslyn T. G., Aschkenazi, Sarit O., Alas, Alexandriah N., Balgobin, Sunil, Balk, Ethan M., et al. (2023). "Nonestrogen Therapies for...